These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8524409)
21. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213 [TBL] [Abstract][Full Text] [Related]
22. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families. Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759 [TBL] [Abstract][Full Text] [Related]
23. THe genetics of familial breast cancer. Cannon-Albright LA; Skolnick MH Semin Oncol; 1996 Feb; 23(1 Suppl 2):1-5. PubMed ID: 8614840 [TBL] [Abstract][Full Text] [Related]
24. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons. Pages S; Caux V; Stoppa-Lyonnet D; Tosi M Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042 [TBL] [Abstract][Full Text] [Related]
25. BRCA: the breast, ovarian, and other cancer genes. Boyd J Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927 [No Abstract] [Full Text] [Related]
26. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition]. Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051 [TBL] [Abstract][Full Text] [Related]
27. Risk of breast cancer in carriers of BRCA gene mutations. Whittemore AS N Engl J Med; 1997 Sep; 337(11):788-9. PubMed ID: 9289641 [No Abstract] [Full Text] [Related]
28. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515 [TBL] [Abstract][Full Text] [Related]
29. Genetic testing for cancer: a complex decision. Harv Womens Health Watch; 2001 Feb; 8(6):2-4. PubMed ID: 11175466 [No Abstract] [Full Text] [Related]
30. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. Ligtenberg MJ; Hogervorst FB; Willems HW; Arts PJ; Brink G; Hageman S; Bosgoed EA; Van der Looij E; Rookus MA; Devilee P; Vos EM; Wigbout G; Struycken PM; Menko FH; Rutgers EJ; Hoefsloot EH; Mariman EC; Brunner HG; Van 't Veer LJ Br J Cancer; 1999 Mar; 79(9-10):1475-8. PubMed ID: 10188893 [TBL] [Abstract][Full Text] [Related]
31. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients. Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560 [TBL] [Abstract][Full Text] [Related]
32. Laboratory identification of hereditary risk of breast and ovarian cancer. Frank TS Curr Opin Biotechnol; 1999 Jun; 10(3):289-94. PubMed ID: 10361081 [No Abstract] [Full Text] [Related]
33. Progress made toward a diagnostic test for breast and ovarian cancer risk. Int J Fertil Menopausal Stud; 1995; 40(3):117. PubMed ID: 7663536 [No Abstract] [Full Text] [Related]
34. [Cloning of the first gene for breast/ovarian cancer (BRCA1), mapping of a second gene locus (BRCA2) and consequences for clinical practice]. Oosterwijk JC; Devilee P; Meijers-Heijboer EJ; Menko FH; Klijn JG; Cornelisse CJ Ned Tijdschr Geneeskd; 1995 Mar; 139(9):421-3. PubMed ID: 7891762 [No Abstract] [Full Text] [Related]
35. A human BRCA1 gene knockout. Boyd M; Harris F; McFarlane R; Davidson HR; Black DM Nature; 1995 Jun; 375(6532):541-2. PubMed ID: 7791869 [No Abstract] [Full Text] [Related]
36. BRCA genes--bookmaking, fortunetelling, and medical care. Healy B N Engl J Med; 1997 May; 336(20):1448-9. PubMed ID: 9145684 [No Abstract] [Full Text] [Related]
37. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Marcus JN; Watson P; Page DL; Narod SA; Lenoir GM; Tonin P; Linder-Stephenson L; Salerno G; Conway TA; Lynch HT Cancer; 1996 Feb; 77(4):697-709. PubMed ID: 8616762 [TBL] [Abstract][Full Text] [Related]
38. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Kelsell DP; Spurr NK; Barnes DM; Gusterson B; Bishop DT Lancet; 1996 Jun; 347(9014):1554-5. PubMed ID: 8684125 [No Abstract] [Full Text] [Related]